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Abstract
Introduction: There is little information about the relationship between hyperuricemia 
and contrast induced nephropathy. The present study aimed to evaluate the relationship 
between hyperuricemia and contrast induced nephropathy among patients, who had 
undergone coronary angiography.
Methods: In the current study, 200 consecutive patients with coronary artery disease, 
who underwent coronary angiography in Modarres hospital, were enrolled. According 
to the available data, the upper limit normal level of uric acid was defined as 7 mg/dl 
in males and 6.5 mg/dl in females. By increasing level of serum creatinine to 0.5 mg/dl 
(or 25% enhancement) from basic level of creatinine during 48 hours of introduction of 
contrast agent, diagnosis of Contrast Induced Nephropathy (CIN) was established. The 
relationship between hyperuricemia and CIN was then assessed.
Results: There is a significant difference between normouricemic patients and 
hyperuricemic patients, in aspect of weight (P = 0.011) and uric acid (P = 0.001); however, 
other quantitative and qualitative variables including age, volume of contract agent, 
creatinine level after angiography, hemoglobin level, gender, arterial access type, number 
of involved vessels, were insignificant between the two groups (P > 0.05). Moreover, 
as an essential finding, CIN was shown in 9% of normouricemic patients and 10% of 
hyperuricemic patients with no significant difference between the two groups (P = 0.6).
Conclusions: Our study suggests that hyperuricemia may not significantly increase the 
rate of the contrast-induced nephropathy in patients, who had undergone angiography.
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Contrast-Induced Nephropathy (CIN) is defined as acute 
reduction kidney function, according to 25% or 0.5mg/dl in-
crease in serum creatinine during 48 hours since introduction 
of contract agent [1, 2]. It is the third cause of acute renal fail-
ure and such patients have high rates of vascular complications 
and longer hospitalization time [3-6]. Renal failure following 
CIN may lead to hemodialysis for the involved patients that 
leads to escalating hospital mortality up to 40% and mortali-
ty during the next two years up to 80%. Hyperuricemia, as a 
risk factor, plays an important role in various types of diseases. 
Nevertheless, there is little information about the relationship 
between hyperuricemia and CIN; for instance, by tubular ob-
struction, uric acid plays its role in pathogenesis of CIN. More-
over, through increasing oxygen radicals, activation of Renin–
Angiotensin System (RAS), rising level of Endothelin 1 and 
inhibition of nitric oxide, hyperuricemia is involved in patho-
genesis of CIN [7-12]. According to increasing rate of coro-
nary angiography and angioplasty, and considering the fact 
that CIN is a relatively common and preventable condition, 
the present study evaluated the relationship between hyperuri-
cemia and contrast induced nephropathy among patients, who 
had undergone coronary angiography.
METHODS
 In the current study, 100 consecutive patients with hyper-
uricemia and 100 consecutive normouricemic patients with 
coronary artery disease, who had undergone coronary angi-
ography at Modarres hospital, during 2013 to 2014, were en-
rolled. According to the available data, the upper limit normal 
level of uric acid was defined as 7 mg/dl in males and 6.5 mg/
dl in females. The exclusion criteria of this study were being 
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pregnant, receiving contract agent during the last week and 
having Glomerular Filtration Rate level (GFR) less than 30.
Increasing level of serum creatinine to 0.5 mg/dl (or 25% en-
hancement) from basic level of creatinine during 48 hours of 
introduction of contrast agent was defined as CIN. The rela-
tionship between hyperuricemia and CIN was assessed. De-
scriptive and analytic studies were performed using the SPSS 
(version 21) software; in order to describe the data, average 
and frequency percentages were used, and Chi square and 
Independent T-test were used for analysis of qualitative and 
quantitative data, respectively. P-values of less than 0.05 were 
considered statically significant. A written informed consent 
was obtained from all participants and the institutional re-
view board approved the study.
RESULTS
The total number of 200 patients enrolled in our study was di-
vided to two groups including: 100 normouricemic patients 
and 100 hyperuricemic patients. In order to compare quan-
titative variables of this study, both groups of patients were 
analyzed by independent T-test. Based on this test, there was 
a significant difference between normouricemic patients and 
hyperuricemic patients, in aspects of weight (P = 0.011) and 
uric acid (P = 0.001); however, other quantitative variables 
including age, volume of contract agent, creatinine level 
before and after angiography and hemoglobin level had no 
significant differences (P > 0.05). In order to compare the 
qualitative variables of both groups of patients (normouri-
cemic patients and hyperuricemic patients), Chi Square test 
was performed. On this basis, the relationship of qualitative 
variables including gender, arterial access type, number of in-
volved vessels, and left ventricular ejection fraction was insig-
nificant between the two groups (P > 0.05).
Moreover, as an important finding, contrast-induced ne-
phropathy was shown in 9% of normouricemic patients and 
10% of hyperuricemic patients that showed no significant dif-
ference between the two groups (P = 0.6).
DISCUSSION
In our study, which was performed to determine the rela-
tionship between hyperuricemia and CIN, according to the 
aforementioned definition, in normouricemic patients 9% 
and in hyperuricemic patients 10% had CIN. The research 
of Omer Toprak et al. on 266 patients, who underwent an-
giography for determining the frequency of CIN among 126 
hyperuricemic patients and 120 normouricemic patients, 
showed that the incidence of CIN in normouricemic and hy-
peruricemic patients was 2.9% and 15.1%, respectively [13, 
14]. In fact, comparing results of the study of Omer Toprak et 
al. with the present study revealed that amongst both groups 
of normouricemic and hyperuricemic patients, other factors 
had interference in occurrence of CIN. Comparing results of 
the present research with the research of Yong Liu et al. on 
patients that had undergone angiography for determining the 
frequency of CIN among 211 hyperuricemic patients and 
577 normouricemic patients showed that the incidence of 
CIN in normouricemic and hyperuricemic patients was 1.4 
and 8.1%, respectively. Results of the study by Yong Liu et 
al. demonstrated that among both groups of normouricemic 
and hyperuricemic patients, other factors including age older 
Table 1: Comparison between of Normouricemia and Hyperuricemia Group
Normouricemia Group (N = 100) Hyperuricemia Group (N = 100) P value
Age 58.93 + 10.76 61.23 + 10.43 NS
Sex (male) 69 (69%) 60 NS
weight (kg) 73.700 ± 12.23 78.380 ± 13.47 0.011
Hypertension 56 63 NS
Diabetes mellitus 30 28 NS
Hyperlipidemia 42 41 NS
Smoker 33 37 NS
creatinine level before angiography (mg/dl) 1.15 ± 0.23 1.15 ± 0.22 NS
creatinine level after angiography (mg/dl) 1.20 ± 0.43 1.41 ± 0.59 NS
Hemoglobin level (mg/dl) 13.42 ± 1.76 13.67 ± 1.81 NS
Uric acid (mg/dl) 4.90 ± 1.24 7.84 ± 1.35 0.001
Redial arterial access 15 15 NS








Volume of contract agent 338.30 ± 142.25 306.20 ± 139.65 NS
Contrast induced nephropathy 9% 10% NS
EF: Left ventricular ejection fraction,
Data are presented as mean ± SD, No (%) and No.
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On the other hand, according to the study of Maryam Pakfetrat 
et al., CIN occurred in 15.5% of patients and revealed that lev-
el of serum creatinine before angiography, volume of contrast 
agent, diabetes mellitus and dehydration had a significant re-
lationship with occurrence of CIN; nevertheless, age, gender 
and level of uric acid had no significant difference among the 
two groups including CIN group and non CIN group [16]. 
The results of these studies and our study suggested that there 
are some controversies about factors that increase the level of 
serum creatinine after angiography, which may be due to differ-
ent conditions and interfering factors of various studies.
Our study suggests that hyperuricemia may not significant-
ly increase the rate of the contrast-induced nephropathy in 
patients, who had undergone angiography. Studies with large 
sample sizes and detailed categorization were recommended 
for future investigations.
REfERENCES
1. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. 
A simple risk score for prediction of contrast-induced nephropathy 
after percutaneous coronary intervention: development and initial 
validation. J Am Coll Cardiol. 2004;44(7):1393-9. DOI: 10.1016/j.
jacc.2004.06.068 PMID: 15464318
2. Schrader R. Contrast material-induced renal failure: an overview. 
J Interv Cardiol. 2005;18(6):417-23. DOI: 10.1111/j.1540-
8183.2005.00081.x PMID: 16336421
3. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit 
Care Clin. 2005;21(2):261-80. DOI: 10.1016/j.ccc.2004.12.003 
PMID: 15781162
4. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medi-
um-induced nephropathy. Kidney Int. 2005;68(1):14-22. DOI: 
10.1111/j.1523-1755.2005.00377.x PMID: 15954892
5. Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on 
the pathogenesis of contrast-induced nephropathy: state of the art. 
Nephrol Dial Transplant. 2005;20(8):1542-50. DOI: 10.1093/ndt/
gfh868 PMID: 16033768
6. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course 
of acute renal insufficiency after cardiac catheterization in patients 
70 years of age or older. A prospective study. Arch Intern Med. 
1990;150(6):1237-42. PMID: 2353856
7. Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible 
implication of hyperuricemia on progression of renal disease. Semin 
Nephrol. 2005;25(1):43-9. PMID: 15660334
8. Dincer HE, Dincer AP, Levinson DJ. Asymptomatic hyperuricemia: 
to treat or not to treat. Cleve Clin J Med. 2002;69(8):594, 7, 600-2 
passim. PMID: 12184468
9. Postlethwaite AE, Kelley WN. Uricosuric effect of radiocontrast 
agents. A study in man of four commonly used preparations. Ann 
Intern Med. 1971;74(6):845-52. PMID: 5580635
10. Mudge GH. Uricosuric action of cholecystographic agents. A pos-
sible factor in nephrotoxicity. N Engl J Med. 1971;284(17):929-33. 
DOI: 10.1056/NEJM197104292841701 PMID: 5551801
11. Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, 
Williams GH, et al. Uric acid and the state of the intrarenal renin-an-
giotensin system in humans. Kidney Int. 2004;66(4):1465-70. DOI: 
10.1111/j.1523-1755.2004.00909.x PMID: 15458439
12. Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, 
Clark VL, et al. Nephropathy requiring dialysis after percutaneous 
coronary intervention and the critical role of an adjusted contrast 
dose. Am J Cardiol. 2002;90(10):1068-73. PMID: 12423705
13. Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyper-
uricemia as a risk factor for contrast‐induced nephropathy in pa-
tients with chronic kidney disease. Cathet Cardiovasc Intervent. 
2006;67(2):227-35. 
14. Toprak O, Cirit M. Risk factors for contrast-induced ne-
phropathy. Kidney Blood Press Res. 2006;29(2):84-93. DOI: 
10.1159/000093381 PMID: 16707906
15. Liu Y, Tan N, Chen J, Zhou Y, Chen L, Chen S, et al. The relation-
ship between hyperuricemia and the risk of contrast-induced acute 
kidney injury after percutaneous coronary intervention in pa-
tients with relatively normal serum creatinine. Clinics (Sao Paulo). 
2013;68(1):19-25. PMID: 23420152
16. Pakfetrat M, Nikoo MH, Malekmakan L, Tabande M, Roozbeh 
J, Reisjalali G, et al. Risk Factors for contrast-related acute kidney 
injury according to risk, injury, failure, loss, and end-stage cri-
teria in patients with coronary interventions. Iran J Kidney Dis. 
2010;4(2):116-22. PMID: 20404421
